Sydney6791,
Thanks for the response again.
If the statement said "the 500-3000k revenue NSP clearly said: * Sales from distribution of existing therapeutic products" then it was not on the document that I saw in the presentation of June 22.
If the S$500K is from existing therapeutic products, then it should not be in the Prime Singapore Budget as those sales should occur irrespective of the PrIme plant!
If you are doing a financial analysis and justification for something then it should be a stand alone analysis - NOT bundled in with existing operations.
This is very important when you are trying to justify new investment money.
Anyway, I have still not had a response from John Manusu and when that comes it should enlighten us all.
Regards............
Sydney6791,Thanks for the response again.If the statement said...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $1.96K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 4699999 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 7039269 | 5 |
View Market Depth
| Last trade - 15.58pm 15/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
